Early Access — free while we kick the tires
EdgarHawk

Jack R Lazar

Director

Director

Latest: Director selling · June 2026

6 filings analyzed · 2 companies · Latest 2026-06-08

Companies

Company Buys Sells Direction
Astera Labs, Inc. ALAB 0 31 Net selling
ThredUp Inc. TDUP 2 0 Net buying

Activity

June 2026
2026-06-08 Astera Labs, Inc. ALAB
low
Sell
10,000 shares
$3,551,679
Significance 4/10

Director Jack R Lazar sells 10,000 shares at $355.17 blended avg ($3.6M) on 2026-06-04; scheduled 10b5-1 plan.

Jack R Lazar (Director) executed 18 separate sales totaling 10,000 shares for $3,551,678.58 on 2026-06-04 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-02, reducing his holdings by 11.7% to 75,688 shares. The transactions are scheduled, not discretionary. His prior sales at ALAB (5 trades on 2025-08-27) showed positive 30-day returns (+8.0% to +11.9%) followed by negative 90-day returns (-18.1% to -20.9%), while his cross-ticker track record on sells shows average 30-day return of +30.0% and average 90-day return of +32.5%. The current stock price of $346.33 is 7.0% below the 52-week high and has risen 73.4% in 30 days and 197.3% in 90 days, though these gains exceed the historical pattern seen in his ALAB sales outcomes.

August 2025
2025-08-28 Astera Labs, Inc. ALAB
high
Sell
22,500 shares
$4,014,398
Significance 6/10

Director Lazar sells 22,500 ALAB shares for $4.0M at $178.42 avg; holds 97.4K post-sale, -18.8% net reduction.

Jack R. Lazar, Director of Astera Labs, executed 5 separate sales totaling 22,500 shares for $4,014,397.74 on 2025-08-27, reducing his holdings from 119,851 to 97,351 shares (-18.8% vs pre-transaction holdings). The blended average price was $178.42, occurring as the stock trades at $189.15 (current price), reflecting a 59.7% gain over the prior 30 days and 108.5% over 90 days. His prior sales at ALAB (5 transactions in 2024–2025) show a 1-in-5 well-timed rate at the 90-day mark, with 4 of 5 sales followed by positive 30-day and 90-day returns, indicating poor timing in prior cycles; however, context matters given the company's high P/E of 315.25, recent 242.2% annual revenue growth (+$191.9M latest quarter), and transition to profitability ($51.2M net income latest quarter after a negative full-year result). The sale scale and timing amid intense price momentum merit scrutiny against underlying financial health and prior execution patterns.

November 2024
2024-11-19 Astera Labs, Inc. ALAB
medium
Sell
12,500 shares
$1,080,439
Significance 6/10

Director LAZAR JACK R sells 12,500 shares of ALAB for $1,080,438.55; stock up +42.3% in 30d, +134.1% in 90d

LAZAR JACK R sold 4 separate tranches totaling 12,500 shares on 2024-11-15 at prices ranging from $85.73 to $88.29 (blended average $86.44), reducing his holdings by 9.3% to 122,500 shares while realizing $1,080,438.55. The transaction occurs after ALAB stock has surged +42.3% over 30 days and +134.1% over 90 days, currently trading at $95.18 near its 52-week high of $99.30. Across his three prior open-market sales (cross-ticker), the insider averaged a 33.4% 30-day return, and at ALAB specifically, his three prior sales on 2024-09-23 were each followed by +32.8% to +33.8% gains over the next 30 days, suggesting a pattern of selling into strong rallies rather than before declines. The company's latest quarter shows negative net income of $-7,593,000.00 against revenue of $113,086,000.00, providing context for the execution of a sale during the stock's sharp appreciation.

September 2024
2024-09-25 Astera Labs, Inc. ALAB
medium
Sell
25,000 shares
$1,268,040
Significance 6/10

Director LAZAR JACK R sells 25,000 ALAB shares at $50.72 avg for $1.3M; stock now $52.10, -39.2% from 52-week high

LAZAR JACK R executed 3 separate sales totaling 25,000 shares for $1,268,039.71 at an average price of $50.72 on 2024-09-23, reducing his position by -15.2% from 165,000 to 140,000 shares. The current price of $52.10 is only 2.7% above the blended sale price but sits significantly below the 52-week high of $85.70, reflecting a -39.2% decline from peak. His prior single trade at ALAB (a buy on 2024-03-22) generated a 90-day return of +75.4%, and his cross-ticker open-market track record shows 3 prior buys with a 100% win rate at the 90-day mark, averaging +75.4% return. However, this sale occurs after the stock has already sustained substantial losses from its highs, not before a decline, and comes as the company reports positive quarterly revenue of $76,850,000 but ongoing net losses of $-7,546,000.

2024-09-04 ThredUp Inc. TDUP
medium
Buy
20,000 shares
$18,844
Significance 4/10

Director LAZAR JACK R buys 20,000 TDUP shares at $0.94; stock now at $0.89, down -78.5% from 52-week high of $4.14

Director LAZAR JACK R purchased 20,000 shares at $0.94 on 2024-09-03, increasing his holdings to 298,258 shares. The transaction occurred as ThredUp's stock has declined sharply: it trades at $0.89 currently, down -78.5% from the 52-week high of $4.14, and has fallen -48.6% in the last 30 days and -52.7% over 90 days. While the insider's cross-ticker track record shows 2 prior buys with strong subsequent returns (avg 90d return +75.4%, 100% win rate), this represents the second purchase at TDUP in four days, and no outcome is yet measurable for the prior 2024-08-30 buy. The company remains unprofitable with net income of $-13,954,000.00 on revenue of $79,755,000.00 in the latest quarter, though annual revenue growth stands at +11.7%.

2024-09-03 ThredUp Inc. TDUP
medium
Buy
10,000 shares
$9,140
Significance 4/10

Director LAZAR JACK R buys 10,000 shares of TDUP at $0.91; stock down -79.2% from 52-week high, company unprofitable.

Director LAZAR JACK R purchased 10,000 shares at $0.91 on 2024-08-30, increasing holdings from 268,258 to 278,258 shares. The purchase occurs as ThredUp trades at $0.86, down -79.2% from its 52-week high of $4.14 and -53.1% over the past 30 days. Fundamentally, the company reported revenue of $79,755,000.00 in the latest quarter with annual revenue growth of +11.7%, but it remains unprofitable with net income of $-13,954,000.00 and a market cap of $96,651,960.00. While the insider's cross-ticker track record shows prior buys with strong 90-day outcomes (average +75.4% return, 100% win rate), the timing pattern of zero well-timed buys at the 90-day mark suggests historical correlation does not reliably predict future results, particularly in a materially distressed valuation environment.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access